Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEAMBOAT: NBI-827104 in Pediatric EECSWS
NCT04625101Phase 2Completed
- Sponsor
- Neurocrine Biosciences
- Start
- Apr 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of NBI-827104 in Epileptic Encephalopathy With Continuous Spike-And-Wave During Slow Sleep (CSWS), sponsored by Neurocrine Biosciences. Started Apr 2021; status: completed.
02
Drugs
NBI-827104
03
Conditions
Epileptic Encephalopathy With Continuous Spike-And-Wave During Slow Sleep (CSWS)
Beyond the preview
Go deeper on NCT04625101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04625101.